AI-Supported Cognitive Rehabilitation for Mild Cognitive Impairment

(ReMind-AI Trial)

Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Kaiser Permanente
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a 12-month program combining AI-guided cognitive exercises and telehealth sessions can improve brain function in older adults with mild cognitive impairment (MCI), a condition that can lead to dementia. Participants will either receive this new AI-supported cognitive rehabilitation intervention or continue with their usual care to determine which is more effective. The researchers aim to assess if the AI-supported approach improves memory, mood, and social engagement over time. Suitable candidates for the trial are English-speaking individuals aged 65 or older, diagnosed with MCI, who can use a computer or mobile device and are not currently receiving behavioral therapy. This trial could provide new insights into supporting cognitive health for those with MCI. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research in cognitive health.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this AI-supported cognitive rehabilitation is safe for older adults with mild cognitive impairment?

Research has shown that using AI for cognitive rehabilitation is generally safe for older adults with mild cognitive impairment (MCI). In one study, older adults used an AI-driven program from home and managed it well, experiencing very few serious side effects. Most participants completed their sessions without major problems, indicating that the treatment is easy to manage. Another review of new technologies, including AI, found these methods practical and helpful, with few reports of harm.

While researchers continue to gather information on long-term safety, these findings suggest that AI-supported cognitive rehabilitation is a safe option for older adults with MCI. Ongoing safety checks in current trials will quickly address any issues that arise.12345

Why are researchers excited about this trial?

Researchers are excited about AI-Supported Cognitive Rehabilitation for mild cognitive impairment because it integrates advanced technology with personalized care. Unlike traditional methods that rely on in-person therapy sessions alone, this approach combines clinician-led telehealth sessions with daily AI-guided cognitive exercises, offering a more flexible and accessible solution. By leveraging AI, the program can adapt exercises to the individual’s progress, potentially enhancing effectiveness and engagement. This innovative blend of technology and healthcare could revolutionize how cognitive decline is managed, providing more tailored and continuous support to those affected.

What evidence suggests that AI-supported cognitive rehabilitation is effective for mild cognitive impairment?

Research has shown that AI in cognitive rehabilitation can enhance thinking skills in older adults with mild memory problems. One study found that participants' thinking skills improved by an average of 18% with AI support, compared to 13% with traditional therapy. Another study demonstrated that AI-based remote therapy can be as effective as direct interaction with a therapist. In this trial, participants will either receive AI-Supported Cognitive Rehabilitation, which combines clinician-delivered telehealth sessions with daily AI-guided cognitive exercises, or continue with their usual care. These findings suggest that integrating AI with cognitive exercises might help maintain or even boost brain health in individuals at risk of dementia. This method leverages technology and remote healthcare, offering a potentially accessible option for those concerned about memory loss.12346

Who Is on the Research Team?

HN

Huong Nguyen, PhD

Principal Investigator

Kaiser Permanente

Are You a Good Fit for This Trial?

This trial is for people aged 65 or older who have mild cognitive impairment, can speak English well enough to participate, score between 13-18 on a specific memory test, can use the internet on a device, and are not currently in behavioral therapy or diagnosed with certain serious mental illnesses.

Inclusion Criteria

I am 65 years old or older.
I have been diagnosed with mild cognitive impairment.
English fluency sufficient to complete study assessments and participate in intervention sessions
See 3 more

Exclusion Criteria

Current receipt of ongoing behavioral health treatment or psychotherapy from a Kaiser Permanente clinician
Diagnosis of bipolar disorder, schizophrenia spectrum disorder, or other serious mental illness that would interfere with participation
I do not have major communication problems that stop me from joining sessions.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 12-month AI-supported cognitive rehabilitation program, including clinician-delivered telehealth sessions and daily AI-guided cognitive exercises

12 months
Bi-weekly telehealth sessions for 6 months, monthly thereafter

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 6 and 12 months

6 months
Assessments at 6 and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • AI-Supported Cognitive Rehabilitation

Trial Overview

The study compares a year-long program of AI-guided brain exercises plus telehealth sessions with usual care. Participants are randomly assigned to either group to see if the new approach helps improve thinking and memory skills.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: AI-Supported Cognitive RehabilitationExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kaiser Permanente

Lead Sponsor

Trials
563
Recruited
27,400,000+

NewDays, Inc.

Collaborator

Citations

AI-Supported Cognitive Rehabilitation for Older Adults With ...

This study will determine whether integrating AI-guided cognitive exercises with clinician-delivered rehabilitation improves cognitive and ...

AI-driven telerehabilitation for older adults with mild ...

Participants were randomized into Group AB (intervention-first) or Group BA (control-first). The intervention consisted of a 5-week home program (24 sessions) ...

Improving Access to Dementia Care through AI‐Powered ...

Patients' cognitive function significantly improved on average by 18% (p <0.001), compared to 13% for traditional outpatient therapy [4, 5]. Self reported ...

A Systematic Review of Neuromodulation, EEG, Virtual ...

This systematic review examines neurotechnological approaches to cognitive rehabilitation in MCI populations, including neuromodulation, electroencephalography ...

AI-Supported Cognitive Rehabilitation for Mild ...

Mild cognitive impairment (MCI) is associated with increased risk of progression to dementia, highlighting the need for accessible interventions to support ...

Immersive Technologies for Cognitive Rehabilitation in ... - PMC

Neurotechnological approaches to cognitive rehabilitation in mild cognitive impairment: a systematic review of neuromodulation, EEG, virtual ...